| Income Statement |
| Total Revenue | 294.40M |
|
| Revenues (USD) | 294.40M |
| Cost of Revenue | 180.70M |
| Gross Profit | 113.70M |
| Operating Expenses | 155.50M |
| Research and Development Expense | 30.00M |
| Selling, General and Administrative Expense | 125.50M |
| Operating Income | -41.80M |
| Income Tax Expense | 1.60M |
| Net Income | -43.40M |
| Net Income Common Stock | -43.40M |
| Net Income Common Stock (USD) | -43.40M |
| Consolidated Income | -43.40M |
| Earnings per Basic Share | -0.56 |
| Earnings per Basic Share (USD) | -0.56 |
| Earnings per Diluted Share | -0.56 |
| Earning Before Interest & Taxes (EBIT) | -41.80M |
| Earning Before Interest & Taxes (USD) | -41.80M |
| Weighted Average Shares | 76.98M |
| Weighted Average Shares Diluted | 76.98M |
| Balance Sheet |
| Cash and Equivalents | 380.30M |
| Cash and Equivalents (USD) | 380.30M |
| Investments | 777.70M |
| Trade and Non-Trade Receivables | 622.50M |
| Property, Plant & Equipment Net | 18.90M |
| Total Assets | 2.01B |
| Total Debt | 206.40M |
| Total Liabilities | 1.51B |
| Accumulated Retained Earnings (Deficit) | -1.54B |
| Accumulated Other Comprehensive Income | -300.00K |
| Shareholders Equity | 499.50M |
| Shareholders Equity (USD) | 499.50M |
| Total Debt (USD) | 206.40M |
| Deferred Revenue | 695.90M |
| Goodwill and Intangible Assets | 27.10M |
| Trade and Non-Trade Payables | 23.00M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 2.40M |
| Net Cash Flow from Financing | 28.20M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -6.20M |
| Capital Expenditure | -4.60M |
| Issuance (Purchase) of Equity Shares | 1.40M |
| Issuance (Repayment) of Debt Securities | 26.80M |
| Net Cash Flow from Investing | -32.20M |
| Net Cash Flow - Investment Acquisitions and Disposals | -27.60M |
| Net Cash Flow from Operations | -3.40M |
| Effect of Exchange Rate Changes on Cash | 1.20M |
| Share Based Compensation | 24.50M |